CpG oligodeoxynucleotides are effective in therapy of minimal residual tumour disease after chemotherapy or surgery in a murine model of MHC class I-deficient, HPV16-associated tumours

REINIŠ, M., ŠÍMOVÁ, J., INDROVÁ, M., BIEBLOVÁ, J., BUBENÍK, J. CpG oligodeoxynucleotides are effective in therapy of minimal residual tumour disease after chemotherapy or surgery in a murine model of MHC class I-deficient, HPV16-associated tumours. International Journal of Oncology. 2007, 30(5), 1247-1251. ISSN 1019-6439. E-ISSN 1791-2423.